SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001932525-23-000002
Filing Date
2023-11-17
Accepted
2023-11-17 16:05:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2964
  Complete submission text file 0001932525-23-000002.txt   4293
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-34620 | Film No.: 231418580
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 100 SUMMER STREET SUITE 2300 BOSTON MA 02110
Business Address
Davis Andrew (Reporting) CIK: 0001932525 (see all company filings)

Type: 144